Serenova A/S: Financial statements 2022
CVR: 30532228
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Serenova A/S (CVR 30532228) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -201,655 and a net result of DKK 6,865,958 compared with DKK 12,888,491 the year before. Equity in the 2022 report amounted to DKK 27,521,103. The solvency ratio was 82.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -201,655
- Profit/Loss
- DKK 6,865,958
- Equity
- DKK 27,521,103
- Total Assets
- DKK 33,219,524
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -202K | 6.9M | 27.5M | 1 |
| 2021 | - | -44K | 12.9M | 20.7M | 1 |
| 2020 | - | -54K | -83.2M | 7.8M | 1 |
| 2019 | - | -36K | -128.5M | 91M | - |
| 2018 | - | 13K | -54.8M | 219.4M | - |
Official annual report
Keep an eye on Serenova A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Serenova A/S has published its annual report for 2021. Gross profit came to DKK -43,552, and the net result was DKK 12,888,491.
About Serenova A/S
Serenova A/S is a Danish company of the type Aktieselskab based in Solrød Strand, founded in 2008. The company is in liquidation. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named SERENDEX PHARMACEUTICALS A/S and SERENDEX A/S. The management consists of Michael Aslo-Petersen. The company is owned by Sorana Holding A/S. The company has 0 employees (2016). In 2025, the company reported a gross profit of DKK -167,993 and a net result of DKK 38,663,045 compared with DKK -24,273,688 the year before. Equity in the 2025 report amounted to DKK 105,405,408.